Van Steenkiste M
J Pharm Belg. 2015 Sep(3):14-23.
This article gives an update on how the composition of the influenza virus vaccine is determined, how the infection spreads, and what the consequences are of the disease. Next flu season for the first time a quadrivalent and intranasal vaccine will be available on the Belgian market. What is the difference with what we know until now? Is there an added value? How about the contraindications? Furthermore we elaborate on the composition of the influenza vaccine on the Belgian market for the season 2015-2016 and we give a reminder of the patient groups with a high risk for complications. As pharmacists we should motivate these patients to get themselves vaccinated. Finally, we discuss the reimbursement conditions of the National Institute for Health and Disability Insurance INIHDII.
本文介绍了流感病毒疫苗的成分如何确定、感染如何传播以及该疾病会带来哪些后果的最新情况。在下一个流感季节，比利时市场将首次有四价鼻内疫苗上市。它与我们目前所了解的有何不同？有附加价值吗？禁忌症是什么？此外，我们详细阐述了2015 - 2016年比利时市场上流感疫苗的成分，并提醒人们注意有并发症高风险的患者群体。作为药剂师，我们应该鼓励这些患者接种疫苗。最后，我们讨论了国家卫生与残疾保险研究所（INIHDII）的报销条件。
